Science Explorer Back to mapMap
Discussion
Researcher · Taiho Pharmaceutical (Japan) · Japan

Kazutaka Miyadera

Kazutaka Miyadera publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer, Hypoxia, and Metabolism, Angiogenesis and VEGF in Cancer and Lung Cancer Treatments and Mutations.

ORCID 0009-0003-4284-9803 OpenAlex
World rank
#1,554,002
of 7,710,434 ranked researchers
Rank in Japan
#25,139
of 383,136
Works
105
Citations
2.5k
Citations per work
23.8
h-index
21
i10-index 26Top 30% in Molecular Biology
Kazutaka Miyadera

What does Kazutaka Miyadera research?

Kazutaka Miyadera's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (41%).

Health Sciences: 45 works · 43.3% of their workMedicine: 45 works · 43.3% of their workOncology: 26 works · 24.7% of their workPulmonary and Respiratory Medicine: 10 works · 9.9% of their workHepatology: 6 works · 5.6% of their workEndocrinology, Diabetes and Metabolism: 3 works · 3.1% of their workLife Sciences: 43 works · 41.4% of their workBiochemistry, Genetics and Molecular Biology: 43 works · 41.4% of their workMolecular Biology: 30 works · 28.4% of their workCancer Research: 14 works · 13.0% of their workEverything else: 16 works · 15.3% of their workTHEIR WORKKazutaka Miyadera105works
Life Sciences41%Health Sciences43%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4543.3%
    1. Biochemistry, Genetics and Molecular Biology4341.4%
  3. Everything else1615.3%
  1. 1Molecular Biology28% of their works
  2. 2Oncology25% of their works
  3. 3Cancer Research13% of their works
  4. 4Pulmonary and Respiratory Medicine10% of their works
  5. 5Hepatology6% of their works
  6. 6Endocrinology, Diabetes and Metabolism3% of their works

Research topics

Which keywords describe Kazutaka Miyadera's research?

The keywords of their largest research topics: Chemotherapy, endothelial progenitor cells, HIF-1, VEGF, Warburg Effect, EGFR Mutations, Targeted Therapy and Cetuximab.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Chemotherapy172 topics
  2. HIF-1161 topic
  3. VEGF161 topic
  4. Warburg Effect161 topic
  5. endothelial progenitor cells161 topic
  6. EGFR Mutations141 topic
  7. Targeted Therapy141 topic
  8. Cetuximab91 topic
  9. KRAS Mutations91 topic
  10. Breast Cancer81 topic
  11. HER281 topic
  12. Enzyme Regulation61 topic
  13. Glycans61 topic
  14. Glycosylation61 topic
  15. Nucleotide Metabolism61 topic
  16. Hepatic Stellate Cells51 topic
  17. Liver Regeneration51 topic

Where does Kazutaka Miyadera work?

Kazutaka Miyadera's main affiliation in the publication record is Taiho Pharmaceutical (Japan), Japan.

How many publications and citations does Kazutaka Miyadera have?

OpenAlex counts 105 works and 2,503 citations for Kazutaka Miyadera, an h-index of 21, ranking #1,554,002 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kazutaka Miyadera. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.